Allworth Financial’s Journey Medical DERM Stock Holding History

Allworth Financial’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206	Buy	+29	New	+$166	﹤0.01%	4956

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Allworth Financial's DERM Position: Q2 2026 in Review

Allworth Financial opened a new position in Journey Medical (DERM) in Q2 2026: 29 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #4956 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Allworth Financial held 29 shares of Journey Medical worth $206 as of Q2 2026.
Journey Medical was a new Allworth Financial position in Q2 2026.
Journey Medical made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4956 holding.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.